Literature DB >> 173974

Glucocorticoid therapy.

L Axelrod.   

Abstract

1. There is a poor relationship between the circulating half-life a glucocorticoid and either its potency or its duration of action. Many actions of a glucocorticoid have unequal durations. The duration of action varies with the dose. 2. The presence of biological activity as a glucocorticoid depends on the presence of a hydroxyl group at carbon number 11. Cortisone and prednisone, which are 11-keto compounds, must be converted to 11-beta-hydroxyl compounds to be effective. This reaction may be impaired in the presence of liver disease. 3. Iatrogenic Cushing's syndrome differs from spontaneous Cushing's syndrome in several respects, possibly because in the former ACTH is suppressed but in Cushing's syndrome associated with bilateral adrenal hyperplasia ACTH levels are elevated...

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 173974     DOI: 10.1097/00005792-197601000-00003

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  60 in total

1.  [The necessity for perioperative cortisol substitution. Spontaneous and stimulated ACTH and cortisol secretion during unilateral adrenalectomy for renal cell carcinoma].

Authors:  P Bischoff; J Noldus; J Harksen; H W Bause
Journal:  Anaesthesist       Date:  1997-04       Impact factor: 1.041

2.  Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease.

Authors:  Mojtaba Akhtari; Cynthia R Giver; Zahir Ali; Christopher R Flowers; Charise L Gleason; Christopher D Hillyer; Jonathan Kaufman; H Jean Khoury; Amelia A Langston; Mary Jo Lechowicz; Sagar Lonial; Heather M Renfroe; John D Roback; Mourad Tighiouart; Louette Vaughn; Edmund K Waller
Journal:  Transfusion       Date:  2010-11       Impact factor: 3.157

Review 3.  Medical management of children with juvenile rheumatoid arthritis.

Authors:  J T Cassidy
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

4.  Intermittent long-term adrenocorticosteroid treatment of myasthenia gravis.

Authors:  N Wakata; Y Kawamura; M Kobayashi; Y Araki; M Kinoshita
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

5.  Potency ratio, clinical equivalence, and wasting ratio estimate of different glucocorticoids.

Authors:  B Imbimbo; S Milani
Journal:  Calcif Tissue Int       Date:  1991-12       Impact factor: 4.333

6.  Vasculitides throughout history and their clinical treatment today.

Authors:  Antonio Iglesias-Gamarra; Edgar Penaranda; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

7.  A randomized clinical trial to compare the efficacy of submucosal aprotinin injection and intravenous dexamethasone in reducing pain and swelling after third molar surgery: a prospective study.

Authors:  Gururaj Arakeri; Kirthi Kumar Rai; H R Shivakumar; Bhushan Jayade
Journal:  J Maxillofac Oral Surg       Date:  2012-05-16

8.  Corticosteroid therapy and intercurrent illness: the need for continuing patient education.

Authors:  S R Peacey; R M Pope; K S Naik; R D Hardern; M D Page; P E Belchetz
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

9.  Short-term bisphosphonate therapy could ameliorate osteonecrosis: a complication in childhood hematologic malignancies.

Authors:  N A Greggio; M Pillon; E Varotto; A Zanin; E Talenti; A C Palozzo; E Calore; C Messina
Journal:  Case Rep Med       Date:  2010-06-10

10.  Management strategies for pulmonary sarcoidosis.

Authors:  Robina Kate Coker
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.